Market players are engaged in product portfolio expansion strategy to boost their market footprint in the lung cancer surgery market, globally.
Future Market Insights, Dubai: The global lung cancer surgery market is slated to register a sturdy CAGR during the forecast period, 2019 to 2029. FMI’s report opines that the usage of techniques that are minimally invasive, robot assisted, and video assisted is expanding, which is determining the future of global market. However, at present the market growth has slowed down owing to the COVID-19 pandemic.
“Growth in robotic thoracic surgery platforms as well as advancement in vessel sealing techniques and tissue-specific endoscopic stapling to limit end leak complications will further widen the development prospects of the lung cancer surgery market.” says an FMI analyst.
Request a report sample to gain comprehensive market insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-396
- East Asia to remain the frontrunner in the market due to high occurrence of lung cancer in Japan & China underpinning demand for lung cancer surgery.
- Surgical energy instruments will be notably preferred for performing lung cancer surgeries throughout the forecast period.
- Robotic-assisted thoracic surgery systems (RATSS) is expected to foresee a noteworthy spike in revenues in the foreseeable future.
- Lobectomy is likely to witness increased adoption, particularly in developed nations.
- Growing prevalence of lung cancer because of growing air pollution levels is driving market growth.
- Rising number of cigarette smokers will enhance the business growth in the near future.
- Rising patient awareness levels, along with adoption of advanced technologically such as robotics is pushing the market growth.
- High cost associated with the robotic surgeries can act as an obstacle in emerging economies amid the forecast period.
- Lack of awareness regarding the surgeries and presence of alternative treatments, might impact the market growth.
Download Market Shares of Leading Players@ https://www.futuremarketinsights.com/ask-question/rep-gb-396
COVID-19 Impact on the Market
The COVID-19 pandemic has laid an unprecedented burden on the healthcare system through first quarter in 2020 that has redirected most of the resources comprising equipment and healthcare professionals towards treating CIVID-19 patients. The lung cancer surgery market is encountering increased challenges due to a higher risk of infection as well as complications of diagnosis amid virus-related symptoms and cancer-related symptoms.
Market players are implementing product portfolio development strategy to boost their market footprint in the worldwide lung cancer surgery market. Some of the key market players operating in the global market are Olympus, Pentax Medical, Intuitive Surgical Inc. and Johnson & Johnson are incessantly engaged on regulatory approvals and new product launches.
For information on the Research Approach used in the Report, Request Methodology@ https://www.futuremarketinsights.com/askus/rep-gb-396
About the Study
The study offers readers a comprehensive assessment of the Lung Cancer Surgery Market. Global, regional and national-level analysis of the latest trends influencing the market is covered in this FMI report. The study provides insights on the basis of product type (thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, and surgical energy instruments), application (lobectomy, segmentectomy, wedge resection, pneumonectomy), end user (hospitals, ambulatory surgical centers), across key regions (North America, Latin America, Europe, China, Asia Pacific, Middle East & Africa).
Explore FMI’s Coverage of the Healthcare Industry
Early-Stage Lung Cancer Diagnostics Therapy Market: Obtain detailed analysis on the early-stage lung cancer diagnostics therapy market through FMI’s report covering competitive analysis, key regions, and segmental analysis for 2018 – 2028.
Small Cell Lung Cancer (SCLC) Treatment Market: Get insights on the Small Cell Lung Cancer (SCLC) treatment market through FMI’s report covering detailed quantitative and qualitative analysis for projection period 2018 – 2028.
Lung Cancer Therapeutics Market: FMI’s exhaustive study on the global lung cancer therapeutics market covers the latest trends, innovations, key players, and popular strategies for the period 2015 – 2025.
About Future Market Insights
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative